Affiliation:
1. Kazan State Medical University
Abstract
The paper presents the results of an assessment cognitive function and ammonium levels in individuals who have had a novel coronavirus infection (COVID-19). The study included 60 people: 41 - confirmed COVID-19 during last 3 months and 19 - the control group. There have been performed clinical examination, psychometric test - connect-the-numbers test (CNT) and Mini-Mental State Examination (MMSE). Blood ammonium level has been determined. Post-COVID-19 syndrome (PCS) was diagnosed in 70.7% of patients, which was manifested by complaints of memory loss, weakness and anxiety. In patients who underwent COVID-19, cognitive impairment was detected on the MMSE scale in 27 people (45%), and the changes were more pronounced in the group with PCS. In the post-COVID group, 66% of the subjects had an increase CNT result. The cognitive impairment according to the MMSE correlated with the CNT results. Hyperammonemia was found in 54% of COVID-19 survivors, with higher values observed in the PCS group. No correlation was found between hyperammonemia and cognitive impairment.
Publisher
LLC Global Media Technology
Subject
Gastroenterology,Hepatology
Reference18 articles.
1. Interim guidelines “Prevention, diagnosis and treatment of new coronavirus infection (COVID-19)”, Version 16. approved. Ministry of Health of Russia 18.08.2022. (in Russ.) Available at: https://edu.rosminzdrav.ru/anonsy/anonsy/news/vremennye-metodicheskie-rekomendacii-profilaktika-d/(Access 01.11.2022.)@@ Vremennye metodicheskie rekomendatsii «Profilaktika, diagnostika i lechenie novoi koronavirusnoi infektsii (COVID-19)», Versiya 16. utv. Minzdravom Rossii 18.08.2022.
2. Soriano J.B., Allan M., Alsokhn C., et al. A clinical case definition of post COVID-19 condition by a Delphi consensus. October 6 2021. Available at: https://apps.who.int/iris/bitstream/handle/10665/345824/WHO-2019-nCoV-Post-COVID-19-condition-Clinical-case-definition-2021.1-eng.pdf?sequence=1&isAllowed=y (Access 01.11.2022.)
3. Bogolepova A.N., Osinovskaya N. A., Kovalenko E. A., Makhnovich E. V. Fatigue and cognitive impairment in post-COVID syndrome: possible treatment approaches. Neurology, Neuropsychiatry, Psychosomatics. 2021;13(4):88-93. (In Russ.) doi: 10.14412/2074-2711-2021-4-88-93.@@ Bogolepova A. N., Osinovskaya N. A., Kovalenko E. A., Makhnovich E. V. Vozmozhnye podkhody k terapii astenicheskikh i kognitivnykh narushenii pri postkovidnom sindrome. Nevrologiya, neiropsikhiatriya, psikhosomatika. 2021;13(4):88-93. doi: 10.14412/2074-2711-2021-4-88-93.
4. Ostroumova T.M., Chernousov P. A., Kuznetsov I. V. Cognitive impairment in COVID-19 survivors. Neurology, Neuropsychiatry, Psychosomatics. 2021;13(1):126-130. (In Russ.) doi: 10.14412/2074-2711-2021-1-126-130.@@ Ostroumova T. M., Chernousov P. A., Kuznetsov I. V. Kognitivnye narusheniya u patsientov, perenesshikh COVID-19. Nevrologiya, neiropsikhiatriya, psikhosomatika. 2021;13(1):126-130. doi: 10.14412/2074-2711-2021-1-126-130.
5. Golovacheva V.A., Tabeeva G. R., Kuznetsov I. V. Cognitive impairment in COVID-19: associations, pathogenesis and treatment questions. Neurology, Neuropsychiatry, Psychosomatics. 2021;13(2):123-129. (In Russ.) doi: 10.14412/2074-2711-2021-2-123-129.@@ Golovacheva V. A., Tabeeva G. R., Kuznetsov I. V. Kognitivnye narusheniya pri COVID-19: vzaimosvyaz', patogenez i voprosy terapii. Nevrologiya, neiropsikhiatriya, psikhosomatika. 2021;13(2):123-129. doi: 10.14412/2074-2711-2021-2-123-129.
Cited by
1 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献